ArticlePDF Available

Abstract and Figures

Over the past two decades, genomics has evolved as a scientific research discipline. Genomics research was fueled initially by government and nonprofit funding sources, later augmented by private research and development (R&D) funding. Citizens and taxpayers of many countries have funded much of the research, and have expectations about access to the resulting information and knowledge. While access to knowledge gained from all publicly funded research is desired, access is especially important for fields that have broad social impact and stimulate public dialogue. Genomics is one such field, where public concerns are raised for reasons such as health care and insurance implications, as well as personal and ancestral identification. Thus, genomics has grown rapidly as a field, and attracts considerable interest. One way to study the growth of a field of research is to examine its funding. This study focuses on public funding of genomics research, identifying and collecting data from major government and nonprofit organizations around the world, and updating previous estimates of world genomics research funding, including information about geographical origins. We initially identified 89 publicly funded organizations; we requested information about each organization's funding of genomics research. Of these organizations, 48 responded and 34 reported genomics research expenditures (of those that responded but did not supply information, some did not fund such research, others could not quantify it). The figures reported here include all the largest funders and we estimate that we have accounted for most of the genomics research funding from government and nonprofit sources. Aggregate spending on genomics research from 34 funding sources averaged around $2.9 billion in 2003-2006. The United States spent more than any other country on genomics research, corresponding to 35% of the overall worldwide public funding (compared to 49% US share of public health research funding for all purposes). When adjusted to genomics funding intensity, however, the United States dropped below Ireland, the United Kingdom, and Canada, as measured both by genomics research expenditure per capita and per Gross Domestic Product.
Content may be subject to copyright.
A preview of the PDF is not available

Supplementary resource (1)

... Sequencing data is now used in various applications, including cancer, rare genetic diseases, microbiome, metagenomics, epidemiology, species conservation, evolutionary biology, crop genomics, and population genomics [87]. This evolution, accompanied by new funding avenues [109] and larger participant cohorts, is leading to a rapid surge in genomic data that demands substantial storage capacity [4], [6], [48], [103]. Further, with the break-out of SARS-CoV-2, we saw an explosion in the amount of sequencing data generated [74] that overwhelmed existing bioinformatics infrastructures [89]. ...
Preprint
Full-text available
The rapid growth of genomic data has positioned genomics to become one of the world's most storage-intensive and computationally demanding fields. This review paper provides a comprehensive analysis of emerging trends in software and hardware for genomics, addressing a critical gap in the current literature. We categorize and examine key algorithms in genomic sequencing workflows, including sequence data indexing, retrieval and pileup , dynamic programming, and machine learning. We analyze how computational and memory requirements scale with input sizes for each category, offering insights into potential bottlenecks and optimization opportunities. Our review synthesizes recent advancements in hardware-software co-design, compression schemes, and acceleration techniques for genomic data processing. We propose graphics processing units (GPUs) as a promising first step for deploying genomics workflows due to their high throughput, memory bandwidth, and programmability. By providing a holistic perspective on the computational challenges in genomics, this paper attempts to set a promising direction for future researchers to work collectively to optimize all the components of genomic data processing workflows. Our work aims to foster more targeted and effective advancements in the field, potentially leading to significant improvements in the efficiency and scalability of genomic analyses. We also discuss performance portability as a second step to meet the diverse requirements in point-of-care workflows.
... As it turns out, much is already being done to try and prevent miscarriages: a great deal of research, involving many millions of pounds, is already being done on the causes of miscarriage. Even in 2005, over $2.9 billion was spent globally on genetics research (Pohlhaus and Cook-Deegan, 2008), while the fertility business makes an estimated $25 billion a year in sales, much of which presumably goes into research on helping pregnancies come to term (The Economist, 2019). Sometimes this research is carried out specifically by pro-life or Catholic organizations (see NaProTechnology, 2020). ...
Article
Full-text available
Several recent papers have suggested that the pro-life view entails a radical, implausible thesis: that miscarriage is the biggest public health crisis in the history of our species and requires radical diversion of funds to combat. In this paper, I clarify the extent of the problem, showing that the number of miscarriages about which we can do anything morally significant is plausibly much lower than previously thought, then describing some of the work already being done on this topic. I then briefly survey a range of reasons why abortion might be thought more serious and more worthy of prevention than miscarriage. Finally, I lay out my central argument: that reflection on the wrongness of killing reveals that the norms for ending life and failing to save life are different, in such a way that could justify the prioritization of anti-abortion advocacy over anti-miscarriage efforts. Such an account can also respond to similar problems posed to the pro-lifer, such as the question of whom to save in a "burning lab" type scenario.
... The role of the knowledge creators is paramount for a research-intensive area similar to this, and the major universities and research institutes will generate the structural, large-scale data to drive this effort. This will require substantial funding; for comparison, genomics research worldwide was publicly funded at about $3B per year from 2003 to 2006, with the United States contributing about 35% of this (44). ...
Article
Full-text available
Proteins are the primary effectors of function in biology, and thus, complete knowledge of their structure and properties is fundamental to deciphering function in basic and translational research. The chemical diversity of proteins is expressed in their many proteoforms, which result from combinations of genetic polymorphisms, RNA splice variants, and posttranslational modifications. This knowledge is foundational for the biological complexes and networks that control biology yet remains largely unknown. We propose here an ambitious initiative to define the human proteome, that is, to generate a definitive reference set of the proteoforms produced from the genome. Several examples of the power and importance of proteoform-level knowledge in disease-based research are presented along with a call for improved technologies in a two-pronged strategy to the Human Proteoform Project.
... The suffix-omics has initially arisen from 'genomics', which is generally defined as the study of whole genomes [17]. Radiomics, which was first proposed by Lambin in 2012 [18], is a relatively 'young' concept and is considered a natural extension of computeraided diagnosis and detection systems [19]. ...
Article
Full-text available
Nasopharyngeal carcinoma (NPC) is one of the most common malignant tumours of the head and neck, and improving the efficiency of its diagnosis and treatment strategies is an important goal. With the development of the combination of artificial intelligence (AI) technology and medical imaging in recent years, an increasing number of studies have been conducted on image analysis of NPC using AI tools, especially radiomics and artificial neural network methods. In this review, we present a comprehensive overview of NPC imaging research based on radiomics and deep learning. These studies depict a promising prospect for the diagnosis and treatment of NPC. The deficiencies of the current studies and the potential of radiomics and deep learning for NPC imaging are discussed. We conclude that future research should establish a large-scale labelled dataset of NPC images and that studies focused on screening for NPC using AI are necessary.
... Funding for genomic research in most developed countries was initiated by governments and non-profit nongovernmental organizations but was later complemented for improved livelihoods (including health, medicine and agriculture) by private research and development (R&D) funding (Pohlhaus and Cook-Deegan [63]). A major hindrance to the implementation and application of agricultural genomic research in Africa is the lack of resources (human and institutional capacities) and funding. ...
Article
Full-text available
Although traditional selective breeding has had a tremendous impact on both livestock and crop production in Africa, this has not kept pace with the high demand for animal and plant products on account of increasing urbanization, improved livelihoods and a rapidly growing human population. These challenges justify the need for more innovative and sustainable ways of improving animal and crop production to meet this demand. Over the last two decades the potential of genomics as a key tool to achieve improvement in desirable phenotypic traits has revolutionized the field of applied animal and plant biology. However, well informed use of such techniques has yet to be fully exploited within the context of local resources and capacity-building. The objective of this review is to highlight the rich agricultural biodiversity of sub-Saharan Africa, the potential of genomics in their sustainable use for food security, the challenges of genomic research and the strategies that can be adopted to overcome them in the implementation of agricultural genomic research in Africa. The lack of state-of-the-art laboratory research facilities, skilled human resources, poor funding and non-availability of scientific research resources, paucity of collaborative links between African researchers and a lack of engagement between key stakeholders in the agricultural value chain were identified as major barriers that affect agricultural genomic research in Africa. Finally, the recommended strategies to overcome these challenges will guide policy-makers, researchers, development partners and key stakeholders in the smooth advancement of sustainable agricultural genomic research for improved food security in Africa.
... More than 60 countries have since established similar national research and development programs (Roco, 2011, p. 428). In many other ground-breaking areas, such as genomics (Pohlhaus & Cook-Deegan, 2008) green energy (National Research Council, 2001;Rodrik, 2014, p. 480) and artificial intelligence (National Research Council U.S., 1999, pp. 7-8), it was often the long-term public investment that led the way, until private sector was able to see the returns through commercialisation. ...
Article
Full-text available
Internet history shows that states, military, universities and other public institutions were essential drivers of innovation in the early stages of network development. However, once risky stages pass, commercialisation starts and investors often reap disproportionate rewards from technological innovation. In this paper, we use the risk-reward nexus (RRN) approach (Lazonick & Mazzucato, 2013 Lazonick, W. , & Mazzucato, M. (2013). The risk-reward nexus in the innovation-inequality relationship: Who takes the risks? Industrial and Corporate Change , 22 (4), 1093–1128. https://doi.org/10.1093/icc/dtt019 [Crossref], [Web of Science ®] , [Google Scholar]; Mazzucato, 2013 Mazzucato, M. (2013). The entrepreneurial state: Debunking public vs. private myths in risk and innovation . Anthem Press. [Google Scholar], 2018 Mazzucato, M. (2018). The value of everything: Making and taking in the global economy . Allen Lane. [Google Scholar]; Mazzucato & Shipman, 2014 Mazzucato, M. , & Shipman, A. (2014). Accounting for productive investment and value creation. Industrial and Corporate Change , 23 (4), 1059–1085. https://doi.org/10.1093/icc/dtt037 [Crossref], [Web of Science ®] , [Google Scholar]) to understand the imbalance between risky public investment and private allocation of rewards regulated by financial markets. We analyse risk reporting in Form 10-K market reports submitted to the Securities and Exchange Commission (SEC) by Google Inc. (Alphabet Inc.) for the period between 2005 and 2019. We detected 58 organisational, marketing and advertising, technological, legal, competitive, and macroeconomic risks. Based on changes in risk reporting three stages of Google’s development can be discerned: post-IPO growth and expansion (2005-2008), growth management and investment diversification (2009-2013), legal struggles and regulatory scrutiny (2014-2019). Reported risks are primarily directed at shareholders, omitting risks relating to internet users, courts, regulators, and nation states. Such an approach is historically rooted in the construction of financial regulation in the name of public interests and markets, with public interests largely interpreted as a proxy for investors’ interests.
Chapter
When evaluating proper delivery models of a genetic service, it is important to take into consideration the healthcare system and the genetic test provided within a specific programme. New delivery models should promote the integration of genetics into all medical specialties through the collaboration among different healthcare professionals and the redistribution of professional roles. The successful implementation of genomic applications into practice must go through the implementation of specific national policies, adequate funding along with increase of professional education in genomics medicine. To that effect, Clinical Decision Support Systems can effectively increase the ability of physicians to assess genetic risk and reduce the possibility of misdiagnosis to improve healthcare. A thorough analysis to understand if genomic information can be used to deliver better health outcomes for patients and populations must be carried out before integrating it into healthcare systems. For this purpose, a conceptual framework of outcomes-based healthcare systems to address whether genomic information can actually deliver value is also presented in this chapter.
Article
Full-text available
The genome of an admixed individual with ancestors from isolated populations is a mosaic of chromosomal blocks, each following the statistical properties of variation seen in those populations. By analyzing polymorphisms in the admixed individual against those seen in representatives from the populations, we can infer the ancestral source of the individual's haploblocks. In this paper we describe a novel approach for ancestry inference, HAPAA (HMM-based analysis of polymorphisms in admixed ancestries), that models the allelic and haplotypic variation in the populations and captures the signal of correlation due to linkage disequilibrium, resulting in greatly improved accuracy. We also introduce a methodology for evaluating the effect of genetic divergence between ancestral populations and time-to-admixture on inference accuracy. Using HAPAA, we explore the limits of ancestry inference in closely related populations.
Article
in a few weeks by a single graduate student with access to DNA samples and associated phenotypes, an Internet connection to the public genome databases, a thermal cycler and a DNA-sequencing machine. With the recent publication of a draft sequence of the mouse genome,, identification of the mutations underlying a vast number of interesting mouse phenotypes has simi-larly been greatly simplified. Comparison of the human and mouse sequences shows that the proportion of the In contemplating a vision for the futureof genomicsresearch,itisappropri-ate to consider the remarkable path that has brought us here. The rollfold (Figure 1) shows a timeline of land-mark accomplishments in genetics and genomics, beginning with Gregor Mendel's discovery of the laws of heredity, and their rediscovery in the early days of the twentiethcentury. Recognitionof DNAasthe hereditary material,, determination of its structure,, elucidation of the genetic code,, development of recombinant DNA tech-nologies,,and establishment of increasingly automatable methods for DNA sequen-cing,-,set the stage for the Human Genome Project (HGP) to begin in 1990 (see also www. nature. com/nature/DNA50). Thanks to the vision of the original planners, and the creativity and determination of a legion of talented scientists who decided to make this project their overarching focus, all of the initial objectives of the HGP have now
Article
Many achievements in the genome sciences have been facilitated by policies that have prioritized genome research, secured funding and raised public and health-professional awareness. Such policies should address ethical, legal and social concerns, and are as important to the scientific and commercial development of the field as the science itself. On occasion, policy issues take precedence over science, particularly when impasses are encountered or when public health or money is at stake. Here we discuss the spectrum of current issues and debates in genome policy, and how to actively engage all affected stakeholders to promote effective policy making.
Article
Alan Krensky has been put in charge of a controversial new office responsible for charting the progress of the NIH Roadmap for Medical Research. Meredith Wadman catches up with him in his first few days on the job.
Article
ASTRONOMYAstronomers observing a supermassive black hole 3.5 billion light-years from Earth have found that the object brightened dramatically at just the time the equations of general relativity predicted.